Non-alcoholic fatty liver disease and metabolic syndrome in overweight adolescents

Authors

DOI:

https://doi.org/10.15343/0104-7809.202448e16332024P

Keywords:

Metabolic Syndrome, Hepatic Steatosis, Adolescent

Abstract

Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of fat in the liver and may be associated with metabolic syndrome (MS). Metabolic syndrome is considered a cluster of metabolic alterations, including lipid, glycemic, and blood pressure disturbances, along with excess abdominal adiposity. The coexistence of these two conditions may predispose individuals to increased cardiovascular risk and mortality. The relevance of this study stands out in the Brazilian context, where the rising cases of NAFLD and MS in adolescents reflect a global trend but lack sufficient investigation into their interconnections within the national scenario. The objective of this study was to investigate the prevalence and relationship between NAFLD and MS in overweight adolescents, as well as to explore the magnitude of their association and the risk factors involved. A cross-sectional study with observational data analysis was conducted at a State Pediatric Hospital in São Paulo. The sample consisted of 67 adolescents aged 10 to 19 years, diagnosed as overweight. All participants underwent anthropometric evaluation, and biochemical and NAFLD data were collected from electronic medical records. For the diagnosis of metabolic syndrome (MS), the International Diabetes Federation criteria were used as a reference. In the total sample, the prevalence of NAFLD and MS was 47.8% and 53.1%, respectively. A significant association was observed between the presence of NAFLD and MS, with NAFLD being more prevalent in the group of adolescents with MS (63.9%) compared to the group without MS (39.1%). The presence of MS was associated with a 3.45 times higher likelihood of a NAFLD diagnosis. Adolescents with NAFLD had significantly higher values of weight, BMI, LDL cholesterol concentrations, and diastolic blood pressure compared to the group without NAFLD. Among the metabolic parameters, LDL cholesterol concentrations and BMI were associated with an increased likelihood of NAFLD. The findings of this study indicate a high prevalence of NAFLD and MS in overweight adolescents, as well as a significant association between these conditions, with particular emphasis on LDL cholesterol concentrations and BMI. Considering MS as a platform for the development of non-communicable chronic diseases and its association with hepatic steatosis, these findings serve as a warning for the adoption of preventive measures starting from the pediatric stage.

Downloads

Download data is not yet available.

References

World Health Organization. Obesidade [Internet]. Genebra: World Health Organization; 2024 [Acesso em 12 nov 2024]. Disponível em: https://www.who.int/health-topics/obesity#tab=tab_13

Instituto Brasileiro de Geografia e Estatística. IBGE [Internet]. Rio de Janeiro: Instituto Brasileiro de Geografia e Estatística; 2016 [Acesso em 12 nov 2024]. Disponível em: https://www.ibge.gov.br/estatisticas/sociais/educacao/9134-pesquisa-nacional-de-saudedo-escolar.html

World Obesity Federation. World Obesity Federation Global Obesity Observatory [Internet]. 2022 [acesso em 4 mar 2023]. Disponível em: https://data.worldobesity.org/publicaton/?cat=19.

Booth A, Magnuson A, Fouts J, Foster MT. Adipose tissue: an endocrine organ playing a role in metabolic regulation. Horm Mol Biol Clin Investig [Internet]. 2016 [acesso em nov 2024];26(1):25-42. doi:10.1515/hmbci-2015-0073. Disponível em: https://pubmed.ncbi. nlm.nih.gov/26910750/

Zimmet P, Alberti KGM, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatric Diabetes [Internet]. 2007 out [acesso em mai 2024];8(5):299–306. doi:10.1111/j.1399-5448.2007.00271.x Disponível em: https://pubmed.ncbi.nlm.nih.gov/17850473/

Eslam M, Alkhouri N, Vajro P, Baumann U, Weiss R, Socha P, et al. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. The Lancet Gastroenterology & Hepatology. 2021 out [acesso em mai 2024];6(10):864–73. doi:10.1016/S2468-1253(21)00183-7. Disponível em: https://pubmed.ncbi.nlm.nih.gov/34364544/

Lee EJ, Choi M, Ahn SB, et al. Prevalence of nonalcoholic fatty liver disease in pediatrics and adolescents: a systematic review and meta-analysis [published correction appears in World J Pediatr. 2024 Oct 16 [acesso em nov 2024]. doi: 10.1007/s12519-024-00838-7]. World J Pediatr. 2024;20(6):569-580. doi:10.1007/s12519-024-00814-1. Disponível em: https://pubmed.ncbi.nlm.nih.gov/38771552/

Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2014 [acesso em jan 2024];2(11):901-910. doi:10.1016/S2213-8587(14)70032-4. Disponível em: https://pubmed.ncbi.nlm.nih. gov/24731669/

Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The Liver as an Endocrine Organ-Linking NAFLD and Insulin Resistance. Endocr Rev. 2019 [acesso em mar 2024];40(5):1367-1393. doi:10.1210/er.2019-00034. Disponível em: https://pubmed.ncbi.nlm.nih. gov/31098621/

Dâmaso AR, do Prado WL, de Piano A, et al. Relationship between nonalcoholic fatty liver disease prevalence and visceral fat in obese adolescents. Dig Liver Dis. 2008 [acesso em nov 2024];40(2):132-139. doi:10.1016/j.dld.2007.09.009. Disponível em: https:// pubmed.ncbi.nlm.nih.gov/18082476/

Yi X, Han L, Li L, Zhu H, Li M, Gao S. Adipokine/hepatokines profiling of fatty liver in adolescents and young adults: cross-sectional and prospective analyses of the BCAMS study. Hepatol Int. Published online October 14, 2024 [acesso em nov 2024]. doi:10.1007/ s12072-024-10736-9. Disponível em: https://pubmed.ncbi.nlm.nih.gov/39400684/

de Boom F, Talib A, Roebroek YGM, et al. Non-Invasive Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease in Adolescents with Severe Obesity; Patient Characteristics and Association with Leptin-A Cross-Sectional Overview of Baseline Data from a RCT. Children (Basel). 2024;11(8):965. doi:10.3390/children11080965. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/ PMC11352657/

Ferreira S, Mendes J, Couto D, Ferreira D, Rêgo C. Nonalcoholic Fatty Liver Disease and Continuous Metabolic Syndrome in Adolescents with Overweight/Obesity. Acta Med Port [acesso em nov. 2024]. 2024;37(3):177-186. doi:10.20344/amp.19834. Disponível em: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/19834

Mann JP, De Vito R, Mosca A, et al. Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease. Hepatology. 2016 [acesso em nov 2024];63(3):745-753. doi:10.1002/hep.28374. Disponível em: https://pubmed.ncbi.nlm.nih.gov/26638195/

Resende WB, Caetano CE, Nogueira AC, Xavier S, Costa e Silva RD, Nunes JE, Dos Santos H, Cheik NC. Esteatose hepática não alcoólica: relação com a síndrome metabólica e os fatores de risco cardiovascular em adolescentes obesos. Rev Bras Promoc Saúde. 2014 [acesso em novembro de 2024];27(1):131-9. doi: https://doi.org/10.5020/2421. Disponível em: https://ojs.unifor.br/RBPS/ article/view/2421/pdf

Cardoso AS, Gonzaga NC, Medeiros CCM, Carvalho DF de. Relação entre ácido úrico e os componentes da síndrome metabólica e esteatose hepática não alcoólica em crianças e adolescentes com sobrepeso ou obesidade. J Pediatr (Rio J) [Internet]. 2013 [acesso em nov 2024] ;89(4):412–8. Disponível em: https://doi.org/10.1016/j.jped.2012.12.008).

Duarte MASM, Silva GAP da. Esteatose hepática em crianças e adolescentes obesos. J Pediatr (Rio J) [Internet]. 2011Mar [acesso em nov 2024];87(2):150–6. Disponível em: https://doi.org/10.1590/S0021-75572011000200011

Lira ARF, Oliveira FLC, Escrivão MAMS, Colugnati FAB, Taddei JAAC. Esteatose hepática em uma população escolar de adolescentes com sobrepeso e obesidade. Jornal de Pediatria. 2010 Feb [acesso em nov 2024] ;86(1):45–52. Disponível em: https://doi/org/10.150/ S0021-75572010000100009

Sawyer SM, Azzopardi PS, Wickremarathne D, Patton GC. The age of adolescence. Lancet Child Adolesc Health. 2018 [acesso nov 2024]; 2(3):223-228. doi:10.1016/S2352-4642(18)30022-1. Disponível em: https://pubmed.ncbi.nlm.nih.gov/30169257/

de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for schoolaged children and adolescents. Bull World Health Organ. 2007 [acesso em mar 2024] ;85(9):660-667. doi:10.2471/blt.07.043497. Disponível em: https://pubmed.ncbi.nlm.nih.gov/18026621/

Brasil, Ministério da Saúde. Orientações para a coleta e análise de dados antropométricos em serviços de saúde: Norma Técnica do Sistema de Vigilância Alimentar e Nutricional - SISVAN [Internet]. Brasília: Ministério da Saúde; 2011[acesso em mar 2024. Disponível em: https://bvsms.saude.gov.br/bvs/publicacoes/orientacoes_coleta_analise_dados_antropometricos.pdf

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985 jul [acesso em fev 2024];28(7):412– 9. Disponível em: https://link.springer.com/article/10.1007%2FBF00280883

Ezenwuba BN, Hynes CM. Ultrasound screening of paediatric non-alcoholic fatty liver disease (NAFLD): A critical literature review. Radiography (Lond). 2024 [acesso em nov 2024];30(5):1317-1325. doi:10.1016/j.radi.2024.07.006. Disponível em: https://pubmed. ncbi.nlm.nih.gov/39059181/

Cassidy FH, et al. Fatty liver disease: MR imaging techniques for the detection and quantification of liver steatosis. Radiographics. 2009 [acesso em nov 2024] ;29:231–260. doi: 10.1148/rg.291075123. Disponível em: https://pubs.rsna.org/doi/abs/10.1148/ rg.291075123?journalCode=radiographics

Tovo CV, Villela-Nogueira CA, Leite NC, et al. Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD). Ann Hepatol. 2019 [acesso em nov 2024];18(3):445-449. doi:10.1016/j.aohep.2018.09.003. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31031166/

Paiva MHP de, Miranda Filho VA, Oliveira ARS de, Cruz KJC, Araújo RMS de, Oliveira KA de. Prevalence of metabolic syndrome and its components in Brazilian adolescents: a systematic review and meta-analysis. Rev paul pediatr [Internet]. 2023;41:e2021145. doi: 10.1590/1984-0462/2023/41/2021145. Disponível em: https://doi.org/10.1590/1984-0462/2023/41/2021145

Masquio DC, Ganen Ade P, Campos RM, et al. Cut-off values of waist circumference to predict metabolic syndrome in obese adolescents. Nutr Hosp. 2015 [acesso em nov 2024] ;31(4):1540-1550. doi:10.3305/nh.2015.31.4.8442. Disponível em: https://www. aulamedica.es/nh/pdf/8442.pdf

Seixas RBPM. Avaliação da esteatose hepática em crianças e adolescentes obesos e com sobrepeso e sua associação com a resistência insulinca [dissertação]. Brasília: Universidade de Brasília; 2010. Disponível em: https://repositorio.unb.br/jspui/ bitstream/10482/8565/1/2010_RenataBel%C3%A9mPess%C3%B4adeM%C3%A9loSeixas.pdf.

Noubiap JJ, Nansseu JR, Lontchi-Yimagou E, et al. Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis. Lancet Child Adolesc Health. 2022 [acesso em fev 2024];6(3):158-170. doi:10.1016/S2352-4642(21)00374-6. Disponível em: https://www.thelancet.com/journals/lanchi/article/ PIIS2352-4642(21)00374-6/abstract

Zhang X, Wu M, Liu Z, et al. Increasing prevalence of NAFLD/NASH among children, adolescents and young adults from 1990 to 2017: a population-based observational study. BMJ Open. 2021 [acesso em nov 2024];11(5):e042843. doi:10.1136/ bmjopen-2020-042843. Disponível em: https://bmjopen.bmj.com/content/11/5/e042843

Udoh UA, Sanabria JD, Rajan PK, et al. Non-Alcoholic Fatty Liver Disease Progression to Non-Alcoholic Steatohepatitis-Related Primary Liver Cancer. In: Sergi CM, ed. Liver Cancer. Brisbane (AU): Exon Publications; April 6, 2021 [accesso em nov 2024]. Disponível em: https://pubmed.ncbi.nlm.nih.gov/33905196/

Moon JH, Kim W, Koo BK, Cho NH; Innovative Target Exploration of NAFLD (ITEN) consortium. Metabolic Dysfunction-Associated Fatty Liver Disease Predicts Long-term Mortality and Cardiovascular Disease. Gut Liver. 2022 [acesso em nov 2024];16(3):433-442. doi:10.5009/gnl210167. Disponível em: https://pubmed.ncbi.nlm.nih.gov/34635626/

Clemente APG, Dal Molin Netto B, Carvalho-Ferreira JP de, Campos RM da S, Ganen A de P, Tock L, et al.. Waist circumference as a marker for screening nonalcoholic fatty liver disease in obese adolescents. Rev paul pediatr [Internet]. 2016 Jan [acesso em nov 2024];34(1):47–55. Disponível em: https://www.sciencedirect.com/science/article/pii/S2359348215000627?via%3Dihub

Xing Y, Fan J, Wang HJ, Wang H. Comparison of MAFLD and NAFLD Characteristics in Children. Children (Basel). 2023 Mar 16;10(3):560. doi: 10.3390/children10030560. PMID: 36980118; PMCID: PMC10047180

Raya-Cano E, Molina-Luque R, Vaquero-Abellán M, Molina-Recio G, Jiménez-Mérida R, Romero-Saldaña M. Metabolic syndrome and transaminases: systematic review and meta-analysis. Diabetol Metab Syndr. 2023 [acesso em nov 2024];15(1):220. doi:10.1186/ s13098-023-01200-z. Disponível em: https://pubmed.ncbi.nlm.nih.gov/37899468/

Chaves GV, Souza DS de, Pereira SE, Saboya CJ, Peres WAF. Associação entre doença hepática gordurosa não alcoólica e marcadores de lesão/função hepática com componentes da síndrome metabólica em indivíduos obesos classe III. Rev Assoc Med Bras [Internet]. 2012May [acesso em nov 2024];58(3):288–93. Disponível em: https://doi.org/10.1590/S0104-42302012000300007

Brennan PN, Dillon JF, Tapper EB. Gamma-Glutamyl Transferase (γ-GT) - an old dog with new tricks?. Liver Int. 2022 [acesso em nov 2024];42(1):9-15. doi:10.1111/liv.15099. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC11165564/

Li S, Wang A, Tian X, Zuo Y, Meng X, Zhang Y. Elevated gamma-glutamyl transferase levels are associated with stroke recurrence after acute ischemic stroke or transient ischemic attack. CNS Neurosci Ther. 2022 [acesso em nov 2024];28(10):1637-1647. doi:10.1111/ cns.13909. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC9437228/

Kosmalski M, Frankowski R, Deska K, Różycka-Kosmalska M, Pietras T. Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds. Nutrients. 2023 [acesso em nov 2024];15(13):2838. doi:10.3390/nu15132838. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC10343927/

Dâmaso AR, Masquio DCL, Campos RMDS, Corgosinho FC, Cercato C. Effects of multidisciplinary therapy on energy balance, inflammation, and metabolic diseases in adolescents with obesity: A narrative review. Ann N Y Acad Sci. Published online November 16, 2024 [acesso em nov 2024]. doi:10.1111/nyas.15251. Disponível em: https://nyaspubs.onlinelibrary.wiley.com/doi/10.1111/ nyas.15251

Wang R, Yan R, Jiao J, et al. Fruit and vegetable intake and the risk of non-alcoholic fatty liver disease: a meta-analysis of observational studies. Front Nutr. 2024 [acesso em nov 2024];11:1398184. Published 2024 Jun 21. doi:10.3389/fnut.2024.1398184. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC11224539/

Sohouli MH, Bagheri SE, Fatahi S, Rohani P. Os efeitos das intervenções para perda de peso em crianças e adolescentes com doença hepática gordurosa não alcoólica: uma revisão sistemática e meta-análise. Obes Sci Pract. 2024 [acesso em nov 2024];10(3):e758. Publicado em 26 de abril de 2024. doi:10.1002/osp4.758. Disponível em: https://onlinelibrary.wiley.com/doi/10.1002/osp4.758

World Health Organization. Report of the Commission on Ending Childhood Obesity [Internet]. Geneva: World Health Organization; 2016. [Acesso em nov 2024]. Disponível em: https://www.who.int/publications/i/item/9789241510066

Published

2024-12-11

How to Cite

Moraes, L. F. H. de, Fernandes, V. de F. T., Salustriano, I. K. M., Reis, G. B., Neto, G. de P. C., Figueiredo, C. C., Evangelista, N. M. de A., & Masquio, D. C. L. (2024). Non-alcoholic fatty liver disease and metabolic syndrome in overweight adolescents. O Mundo Da Saúde, 48. https://doi.org/10.15343/0104-7809.202448e16332024P